BusinessSECURITIES NOTICE: Rosen Law Firm Reminds Esperion Therapeutics, Inc. Investors of Important March 14, 2016 Deadline in Class Action – ESPRBy Nasdaq OMXMar 4, 2016, 8:30 PM UTC
BusinessMedical Marijuana, Inc. Portfolio Investment Company, Kannalife Sciences, Inc. Notified of DEA Clearance for Import of High-Purity, Pharmaceutical-Grade Cannabidiol (CBD)By Nasdaq OMXMar 1, 2016, 2:00 PM UTC
BusinessMedical Marijuana, Inc.’s HempMeds® México Offers Details for Importation of RSHO-X When Purchased in the U.S.By Nasdaq OMXFeb 24, 2016, 2:00 PM UTC
BusinessEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against GoPro, Inc. – GPROBy Nasdaq OMXFeb 22, 2016, 10:59 PM UTC
BusinessMedical Marijuana, Inc.’s Zero-THC Cannabidiol (CBD) Hemp Oil, RSHO-X™ From HempMeds®, Featured at Southwest Cannabis Conference in Fort Worth, TXBy Nasdaq OMXFeb 22, 2016, 2:00 PM UTC
BusinessEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against KLX, Inc. – KLXIBy Nasdaq OMXFeb 18, 2016, 8:24 PM UTC
BusinessMedical Marijuana, Inc. Portfolio Investment Company, Kannalife Sciences, Inc. Receives Publication Through American Chemical Society for KLS-13019, a Novel Cannabidiol-Derived Target Drug Candidate for Hepatic EncephalopathyBy Nasdaq OMXFeb 18, 2016, 2:00 PM UTC
BusinessKannalife Sciences Announces Publication of “Discovery of KLS-13019, a Cannabidiol-Derived Neuroprotective Agent, With Improved Potency, Safety and Permeability”By Nasdaq OMXFeb 16, 2016, 4:16 PM UTC
